| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 66.3754 | 68 |
| GSM780708 | Untreated after 4 days (C2_1) | 73.0284 | 70 |
| GSM780709 | Untreated after 4 days (C3_1) | 55.4328 | 60 |
| GSM780719 | Untreated after 4 days (C1_2) | 75.5383 | 71 |
| GSM780720 | Untreated after 4 days (C2_2) | 56.2797 | 61 |
| GSM780721 | Untreated after 4 days (C3_2) | 61.0899 | 65 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 63.2295 | 66 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 78.9762 | 71 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 72.2994 | 70 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 63.365 | 66 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 74.6626 | 70 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 70.5765 | 69 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 94.2458 | 74 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 82.1922 | 72 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 72.6129 | 70 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 74.7421 | 70 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 74.4008 | 70 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 62.9142 | 66 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 57.6488 | 63 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 76.4478 | 71 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 59.8785 | 64 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 70.6554 | 69 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 69.618 | 69 |